Authorisation process

Phase II: Recommendation for inclusion in the Authorisation List

Phase II takes about one to one and a half years and consists of the following steps:

Scroll down


ECHA regularly assesses the substances from the Candidate List to determine which ones should be included in the Authorisation List as a priority.

This prioritisation is based primarily on information in registration dossiers on uses and volumes of the substance in the scope of authorisation. It also takes into account information received during the SVHC consultation or other sources, if relevant.

Priority is given to substances with :

Additional aspects relevant for the recommendation can be considered.

Learn more

Draft recommendation

Based on the prioritisation, a number of substances are proposed in the draft recommendation. For each substance, the draft recommendation includes:

Learn more


ECHA’s draft recommendation is submitted for consultation, which typically runs for three months once every one to one and a half years.

Learn more

MSC opinion

The Member State Committee provides an opinion on the draft recommendation to ECHA, taking into account the comments received during the consultation.

Recommendation and inclusion in the Authorisation List

ECHA finalises the recommendation, taking into account the MSC opinion and the comments received during the consultation. The recommendation is then submitted by ECHA to the European Commission.

Learn more
Learn more